GLP-1s Boost IBD Outcomes in Patients With T2D and Obesity ...Middle East

Medscape - News
The use of GLP-1s is linked to improved inflammatory bowel disease outcomes in patients with concomitant inflammatory bowel disease and type 2 diabetes, specifically in those with obesity. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( GLP-1s Boost IBD Outcomes in Patients With T2D and Obesity )

Also on site :